Business
Naira hits new lows against Dollar, Euro as currency woes persist
The Nigerian currency, the naira, suffered another setback on Wednesday, March 5, 2025, as it weakened against the United States dollar in both the official and parallel markets.
At the official exchange window, the naira depreciated to N1,500.80 per dollar, marking a loss of N9.13 compared to N1,491.67/$1 recorded the previous day.
The depreciation was even more pronounced in the black market, where the naira slid further to N1,525/$1, a significant drop of N15 from the N1,510/$1 rate of the preceding day.
READ ALSO: BDCs struggle to access forex from Banks as parallel market trades lower than interbank rates
Meanwhile, the local currency maintained stability against the British pound, trading at N1,900/£1, unchanged from the previous day’s rate. Similarly, the exchange rate for the Canadian dollar remained fixed at N1,200/CA$1.
However, the naira took a sharp plunge against the euro, falling to ₦1,605/€1, a dramatic loss of N35 compared to the previous day’s rate of ₦1,570/€1.
The latest decline in the naira’s value highlights ongoing concerns over Nigeria’s foreign exchange market, with pressures mounting from dwindling dollar inflows, inflation, and policy uncertainties.
Financial analysts warn that unless decisive measures are taken to stabilize the forex market, the naira may continue its downward trajectory in the coming weeks.
-
Football1 week agoXabi Alonso targets Arda Guler as Chelsea prepare €100m transfer bid
-
Football1 week agoFIFA confirms Jay-Jay Okocha holds World Cup record
-
Business7 days agoDangote cuts petrol, diesel prices again to boost affordability, economic activity
-
Aviation1 week agoInside Airport Luggage Theft: Experts warn of rising insider syndicates
-
Politics1 week agoAmuwo Odofin: Umeadi emerges winner of NDC Reps Primary
-
Featured1 week agoPSG edge Arsenal on penalties to retain Champions League crown
-
Football1 week agoChampions League Final: Talking points ahead of Arsenal vs. PSG match
-
Health4 days agoSenate hearing set to review research on COVID-19 vaccines, cancer concerns

